Skip to Content

Russell Inv US Small Cap Equity C RLECX

Medalist Rating as of | See Russell Investments Investment Hub
  • NAV / 1-Day Return 22.25  /  −0.76 %
  • Total Assets 853.0 Mil
  • Adj. Expense Ratio
    2.020%
  • Expense Ratio 2.130%
  • Distribution Fee Level Average
  • Share Class Type Level Load
  • Category Small Blend
  • Investment Style Small Blend
  • Min. Initial Investment
  • Status Open
  • TTM Yield
  • Turnover 80%

USD | NAV as of Apr 25, 2024 | 1-Day Return as of Apr 25, 2024, 11:17 PM GMT+0

Morningstar’s Analysis RLECX

Will RLECX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Weakness in Russell Inv US Small Cap Equity C's People and Process Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings RLECX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 9.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Russell 2000 E-Mini Index Futures

4.12 39.4 Mil

U.S. Cash Management Fund

3.98 38.0 Mil
Cash and Equivalents

Viking Therapeutics Inc

0.69 6.6 Mil
Healthcare

Super Micro Computer Inc

0.65 6.2 Mil
Technology

LeMaitre Vascular Inc

0.65 6.2 Mil
Healthcare

UFP Technologies Inc

0.60 5.7 Mil
Healthcare

Aris Water Solutions Inc Class A

0.57 5.4 Mil
Utilities

Kaiser Aluminum Corp

0.55 5.2 Mil
Basic Materials

Netstreit Corp Ordinary Shares

0.53 5.1 Mil
Real Estate

Rocket Pharmaceuticals Inc

0.47 4.5 Mil
Healthcare